{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medrol-dose+pack+%28Steroid%29", "query": { "intervention": "Medrol-dose pack (Steroid)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Medrol-dose+pack+%28Steroid%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T06:05:45.694Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06453083", "title": "Medrol Dose Packs for Post-Operative Pain Control", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Medrol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "10 Years to 21 Years" }, "enrollment_count": 57, "start_date": "2023-01-13", "completion_date": "2024-12-17", "has_results": false, "last_update_posted_date": "2025-01-07", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06453083" }, { "nct_id": "NCT02176031", "title": "Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "Natalizumab", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2015-01", "completion_date": "2019-02", "has_results": true, "last_update_posted_date": "2020-04-17", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02176031" }, { "nct_id": "NCT03139604", "title": "GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Graft-versus-host Disease (GVHD)" ], "interventions": [ { "name": "Itacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 439, "start_date": "2017-07-19", "completion_date": "2020-07-13", "has_results": true, "last_update_posted_date": "2025-09-02", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 49, "location_summary": "La Jolla, California • Los Angeles, California • Stanford, California + 38 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03139604" }, { "nct_id": "NCT02348216", "title": "Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Refractory Diffuse Large B Cell Lymphoma (DLBCL)", "Relapsed Diffuse Large B-Cell Lymphoma", "Transformed Follicular Lymphoma (TFL)", "Primary Mediastinal B-cell Lymphoma (PMBCL)", "High Grade B-cell Lymphoma (HGBCL)" ], "interventions": [ { "name": "Axicabtagene Ciloleucel", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Levetiracetam", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "High-dose methylprednisolone", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Kite, A Gilead Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 307, "start_date": "2015-04-21", "completion_date": "2023-07-27", "has_results": true, "last_update_posted_date": "2024-06-04", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 23, "location_summary": "Gilbert, Arizona • Duarte, California • La Jolla, California + 19 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348216" }, { "nct_id": "NCT01874860", "title": "Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "Doxycycline", "type": "DRUG" }, { "name": "Hydrocortisone 1% cream", "type": "DRUG" }, { "name": "Sunscreen", "type": "OTHER" }, { "name": "Moisturizer", "type": "OTHER" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Medrol-dose pack (Steroid)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Louisville", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2013-08", "completion_date": "2018-07", "has_results": false, "last_update_posted_date": "2022-12-01", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01874860" }, { "nct_id": "NCT05097976", "title": "Medrol Dosepak for Outpatient Total Knee Arthroplasty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Total Knee Arthroplasty" ], "interventions": [ { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2022-03-01", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 1, "location_summary": "Oak Brook, Illinois", "locations": [ { "city": "Oak Brook", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05097976" }, { "nct_id": "NCT07158476", "title": "Efficacy of Methylprednisolone for Pain Control After ACL Repair", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "ACL Surgery", "Pain Management" ], "interventions": [ { "name": "Meloxicam 15 mg", "type": "DRUG" }, { "name": "Medrol 4 MG Oral Tablet Includes Medrol Dosepak", "type": "DRUG" }, { "name": "Gabapentin 300 mg", "type": "DRUG" }, { "name": "Hydrocodone 5Mg/Acetaminophen 325Mg Tab", "type": "DRUG" }, { "name": "Ketorolac 10 Mg Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Louis University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "13 Years to 50 Years" }, "enrollment_count": 90, "start_date": "2025-10-21", "completion_date": "2031-09", "has_results": false, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07158476" }, { "nct_id": "NCT05003596", "title": "Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Hand Injuries", "Finger Injuries" ], "interventions": [ { "name": "Methylprednisolone Tablet", "type": "DRUG" }, { "name": "Standard Mobilization Treatment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Robert Wood Johnson Barnabas Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2021-09-01", "completion_date": "2023-09-01", "has_results": false, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 2, "location_summary": "Brick, New Jersey • Somerset, New Jersey", "locations": [ { "city": "Brick", "state": "New Jersey" }, { "city": "Somerset", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05003596" }, { "nct_id": "NCT04349410", "title": "The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "CoVid 19 Positive" ], "interventions": [ { "name": "Hydroxychloroquine, Azithromycin", "type": "DRUG" }, { "name": "Hydroxychloroquine, Doxycycline", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin, Primaquine - low dose.", "type": "DRUG" }, { "name": "Hydroxychloroquine, Clindamycin, Primaquine - high dose.", "type": "DRUG" }, { "name": "Remdesivir", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Interferon-Alpha2B", "type": "DRUG" }, { "name": "Losartan", "type": "DRUG" }, { "name": "Convalescent Serum", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Camelot Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1800, "start_date": "2020-04-11", "completion_date": "2020-09-14", "has_results": false, "last_update_posted_date": "2020-11-12", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04349410" }, { "nct_id": "NCT03584516", "title": "GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Graft-versus-host Disease" ], "interventions": [ { "name": "Itacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2019-01-17", "completion_date": "2023-11-03", "has_results": true, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-09-28T06:05:45.694Z", "location_count": 39, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Duarte, California + 30 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03584516" } ] }